CLINICAL_TRIALS
trial_result
· 2009-02-02
Clinical Trial Update: Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA) [Phase 3]
Summary
Phase III open-label comparative study of the rheumatoid arthritis drug MRA completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chugai Pharmaceutical | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED